Teva Pharmaceutical Industries (TEVA) News Today $16.78 +0.21 (+1.27%) (As of 11/29/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Bellevue Group AG Reduces Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Bellevue Group AG decreased its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 54.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 70,821 shares of the company's stock after selling 83,9December 1 at 7:13 AM | marketbeat.comBNP Paribas Financial Markets Sells 548,003 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)BNP Paribas Financial Markets decreased its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 31.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,168,771 shares of the company's stock after selling 5December 1 at 4:13 AM | marketbeat.comGoldentree Asset Management LP Sells 180,657 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Goldentree Asset Management LP lowered its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 7.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,304,993 shares of the company's stockNovember 29 at 8:39 AM | marketbeat.com1,349,274 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Purchased by Sio Capital Management LLCSio Capital Management LLC acquired a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,349,274 shares of thNovember 29 at 7:57 AM | marketbeat.comVinva Investment Management Ltd Raises Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Vinva Investment Management Ltd raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 964.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 217,720 shares of the compNovember 29 at 6:31 AM | marketbeat.comPublic Sector Pension Investment Board Grows Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Public Sector Pension Investment Board raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 23.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 580,967November 29 at 6:09 AM | marketbeat.comBlueshift Asset Management LLC Buys New Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Blueshift Asset Management LLC bought a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 41,086 shares of the cNovember 28 at 6:57 AM | marketbeat.comFmr LLC Buys 20,762,226 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Fmr LLC raised its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 49.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,740,763 shares of the company's stock afterNovember 28 at 5:46 AM | marketbeat.comRubric Capital Management LP Lowers Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Rubric Capital Management LP lessened its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 7.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,005,498 shares of the company's stoNovember 27, 2024 | marketbeat.com2 Generic Drug Stocks Ready to Surge in 2025 (TEVA)Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.November 27, 2024 | marketbeat.comTeva Pharmaceutical Industries Ltd: Teva to Present at the 7th Annual Evercore ISI HealthCONx ConferenceNovember 26, 2024 | finanznachrichten.deTeva to Present at the 7th Annual Evercore ISI HealthCONx ConferenceNovember 25, 2024 | globenewswire.comPitcairn Co. Takes $947,000 Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Pitcairn Co. acquired a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 52,575 shares of the company's stock, valued at approximately $947,000November 25, 2024 | marketbeat.comThrivent Financial for Lutherans Has $4.05 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Thrivent Financial for Lutherans lifted its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 21.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 224,511 shares of the companNovember 25, 2024 | marketbeat.comOkabena Investment Services Inc. Purchases New Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Okabena Investment Services Inc. acquired a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 58,776 shares of the company's stock, valued at approximately $1,059,November 24, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Average Recommendation of "Moderate Buy" from BrokeragesTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine brokerages that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and seven have issued aNovember 24, 2024 | marketbeat.comNatixis Advisors LLC Sells 32,485 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Natixis Advisors LLC trimmed its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 16.1% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 168,867 shares of the company's stock after selling 32,485 shares during the qNovember 24, 2024 | marketbeat.comClal Insurance Enterprises Holdings Ltd Has $621.34 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Clal Insurance Enterprises Holdings Ltd grew its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,543,812 shares of the company's stock afterNovember 23, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) EVP Christine Fox Sells 19,388 SharesNovember 22, 2024 | insidertrades.comConnor Clark & Lunn Investment Management Ltd. Buys New Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 823,544November 21, 2024 | marketbeat.comTeva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25November 21, 2024 | finance.yahoo.comFactorial Partners LLC Increases Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Factorial Partners LLC boosted its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 14.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 311,000 shares ofNovember 20, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Jefferies London Healthcare Conference (Transcript)November 19, 2024 | seekingalpha.comTeva Pharmaceutical: Community Routes: Access to Mental Health CareNovember 18, 2024 | finanznachrichten.deTeva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Down - Should You Sell?Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Down - Should You Sell?November 15, 2024 | marketbeat.comKing Wealth Management Group Acquires New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)King Wealth Management Group bought a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 98,102 shares of the companNovember 15, 2024 | marketbeat.comPlato Investment Management Ltd Makes New $1.14 Million Investment in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Plato Investment Management Ltd bought a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 63,530 shares of the company's stock, valuedNovember 15, 2024 | marketbeat.comSivik Global Healthcare LLC Sells 30,000 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Sivik Global Healthcare LLC trimmed its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 15.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 170,000 shares of the companyNovember 14, 2024 | marketbeat.comWCM Investment Management LLC Takes Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)WCM Investment Management LLC bought a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 60,170 shares of the company's stock, valued at approximately $1,0November 13, 2024 | marketbeat.comFMR LLC Bolsters Stake in Teva Pharmaceutical Industries LtdNovember 12, 2024 | gurufocus.comMivtachim The Workers Social Insurance Fund Ltd. Under Special Management Has $24.97 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lessened its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 4.7% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 1,385,731 shares of the company's stNovember 10, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Migdal Insurance & Financial Holdings Ltd.Migdal Insurance & Financial Holdings Ltd. decreased its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 12.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owNovember 10, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by ARK Investment Management LLCARK Investment Management LLC lowered its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 26.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 123,865 shares of the company's stock afteNovember 9, 2024 | marketbeat.comTeva to Present at the Jefferies London Healthcare ConferenceNovember 8, 2024 | globenewswire.comTeva selloff brings good entry point, says UBSNovember 8, 2024 | markets.businessinsider.comRobeco Institutional Asset Management B.V. Boosts Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Robeco Institutional Asset Management B.V. increased its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 73.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 465,032 shares of the company's stock after acquiriNovember 8, 2024 | marketbeat.comMarket Whales and Their Recent Bets on TEVA OptionsNovember 7, 2024 | benzinga.comStrong Performance and Strategic Initiatives Bolster Buy Rating for Teva PharmaceuticalsNovember 7, 2024 | markets.businessinsider.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | msn.comTeva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ...November 7, 2024 | finance.yahoo.comZacks Research Issues Optimistic Estimate for TEVA EarningsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Investment analysts at Zacks Research upped their FY2024 earnings per share estimates for shares of Teva Pharmaceutical Industries in a report released on Monday, November 4th. Zacks Research analyst R. Department now forecasts thNovember 7, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comTeva Pharm CEO says will work productively with Trump administrationNovember 6, 2024 | reuters.comTeva Pharmaceutical Industries (NYSE:TEVA) Releases FY24 Earnings GuidanceTeva Pharmaceutical Industries (NYSE:TEVA) updated its FY24 earnings guidance. The company provided EPS guidance of $2.40-2.50 for the period, compared to the consensus estimate of $2.45. The company also issued revenue guidance of $16.10-16.50 billionillion, compared to the consensus estimate of $16.27 billionillion.November 6, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited 2024 Q3 - Results - Earnings Call PresentationNovember 6, 2024 | seekingalpha.comTeva Pharmaceutical Industries (NYSE:TEVA) Releases FY 2024 Earnings GuidanceTeva Pharmaceutical Industries (NYSE:TEVA) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.400-2.500 for the period, compared to the consensus estimate of 2.450. The company also issued revenue guidance of $16.1 billionillion-$16.5 billionillion, compared to the consensus estimate of $16.3 billionillion.November 6, 2024 | marketbeat.comTeva Pharma Q3 Beats Market, Lifts FY24 Outlook; Stock UpNovember 6, 2024 | markets.businessinsider.comZacks Research Has Optimistic Outlook of TEVA Q3 EarningsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Stock analysts at Zacks Research raised their Q3 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research note issued on Monday, November 4th. Zacks Research analyst R. Department now anticipates thNovember 6, 2024 | marketbeat.comTeva Pharmaceutical third-quarter profit, revenue top estimatesNovember 6, 2024 | reuters.comTeva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPSNovember 6, 2024 | globenewswire.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼1.080.87▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼158▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News TAK News BNTX News BGNE News MRNA News VTRS News SMMT News GMAB News RDY News PCVX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TEVA Stock Alerts